StockData
Fulcrum Therapeutics, Inc. logo

Fulcrum Therapeutics, Inc. (FULC) stock

FULCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 8/30
$3.75+0.04 (+1.08%)

Close on Nov 17, 2026Market cap $286.12MP/E –Yield –

Fulcrum Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Fulcrum Therapeutics's market cap was $285.31M on Nov 11, 2026, against $591.95M a year earlier. Over the last 5 years it ranged from $130.25M to $960.81M, with a median of $350.51M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$285.31M-53.4%
2025Dec 31, 2025$611.97M+141.4%
2024Dec 31, 2024$253.51M-27.9%
2023Dec 29, 2023$351.67M-7.2%
2022Dec 30, 2022$378.92M-47.1%
2021Dec 31, 2021$716.90M+124.4%
2020Dec 31, 2020$319.43M-14.9%
2019Dec 31, 2019$375.36M–

More Fulcrum Therapeutics figures

See a number that looks wrong?